Correlation Engine 2.0
Clear Search sequence regions


  • ANP (4)
  • cardiovascular disease (4)
  • factor (2)
  • heart (1)
  • humans (1)
  • IL 6 (6)
  • Insulysin (2)
  • MAPK (2)
  • mice (2)
  • protein levels (1)
  • risk factors (1)
  • selumetinib (1)
  • serum (1)
  • Sizes of these terms reflect their relevance to your search.

    Cardiovascular disease (CVD) is a prevalent cause of morbidity and mortality in type I diabetes mellitus (T1DM). However, the pathophysiological mechanisms underlying the relationship between CVD, CVD risk factors, and T1DM have not yet been sufficiently explored. Here, we report that insulin-degrading enzyme (IDE) effectively degrades the precursor of atrial natriuretic peptide (proANP) in HEK293T cells. The pro-inflammatory cytokine IL-6 elicited a significant dose-dependent increase in IDE protein expression. Inhibition of the ERK/MAPK signaling pathway with selumetinib abolished the IL-6-stimulated increase in IDE protein levels and decreased ANP secretion in H9C2 cells. Importantly, the T1DM mouse model displayed lower proANP in the heart and ANP in serum, due to increased IDE expression and activity. Our results suggest a novel role of IL-6 in ANP metabolism via IDE and provide possibilities for new potential therapeutic strategies for diabetes-related cardiovascular complications.

    Citation

    Caiyun Li, Yao Wang, Guozhen Zhu, Yaxian Shang, Jiefang Kang, Jia Li. IL-6 induced enhanced clearance of proANP and ANP by insulin-degrading enzyme in T1DM mice. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2022 Feb;100(1):37-44

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34644519

    View Full Text